The Pune-based Serum Institute of India (SII) and Indian Council of Medical Research (ICMR) on Thursday announced the completion of enrolment of phase-3 clinical trials for potential COVID-19 vaccine Covishield in India. The ICMR and SII have collaborated for the clinical development of Covovax developed by Novavax, US and upscaled by SII, a statement said.from IndiaTV India: Google News Feed https://ift.tt/38wvEA9
via
No comments:
Post a Comment
Please do not enter spam link in the comment box. Suggestions are invited for improvement.